Get started
Author

Nadya Velikova

Observed names: N. Velikova, N.R. Velikova, Velikova, N.R., Velikova, Nadya
ORCID: 0000-0002-9183-4128
Observed ORCID: 0000-0002-9183-4128
OpenAlex ID: A5064036734
Bacterial Histidine Kinases as Novel Antibacterial Drug Targets
2014 · Agnieszka E. Bem, Nadya Velikova, et al. · ACS Chemical Biology · 203
Superinduction of estrogen receptor mediated gene expression in luciferase based reporter gene assays is mediated by a post-transcriptional mechanism
2010 · A.M. Sotoca, T.F.H. Bovee, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 68
Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens
2016 · Nadya Velikova, Simone Fulle, et al. · Scientific Reports · 51
PDF
Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis
2016 · Nadya Velikova, Kevin Kavanagh, et al. · BMC Microbiology · 49
PDF
Broadening the antibacterial spectrum of histidine kinase autophosphorylation inhibitors via the use of ε-poly-L-lysine capped mesoporous silica-based nanoparticles
2016 · Nadya Velikova, Nuria Mas, et al. · Nanomedicine Nanotechnology Biology and Medicine · 25
PDF
Physicochemical-guided design of cathelicidin-derived peptides generates membrane active variants with therapeutic potential
2020 · Nelson G. J. Oliveira, Marlon H. Cardoso, et al. · Scientific Reports · 24
PDF
WalK, the Path towards New Antibacterials with Low Potential for Resistance Development
2013 · Nadya Velikova, Agnieszka E. Bem, et al. · ACS Medicinal Chemistry Letters · 17
PDF
Altered ivermectin pharmacology and defective visual system in Drosophila mutants for histamine receptor HCLB
2008 · Shazie Yusein, Nadya Velikova, et al. · Invertebrate Neuroscience · 17
An acidic model pro-peptide affects the secondary structure, membrane interactions and antimicrobial activity of a crotalicidin fragment
2018 · Nelson G. O. Júnior, Marlon H. Cardoso, et al. · Scientific Reports · 14
PDF
Synthesis and SAR of phenylazoles, active against Staphylococcus aureus Newman
2022 · Vitalii V. Solomin, Blanca Fernandez Ciruelos, et al. · Chemistry of Heterocyclic Compounds · 5
PDF
The VraSR regulatory system contributes to virulence in Streptococcus suis via resistance to innate immune defenses
2018 · Nadya Velikova · Virulence · 5
PDF
Repurposing Hsp90 inhibitors as antimicrobials targeting two-component systems identifies compounds leading to loss of bacterial membrane integrity
2024 · Blanca Fernandez-Ciruelos, Marco Albanese, et al. · Microbiology Spectrum · 4
Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients
2016 · Nadya Velikova, Jerry Wells · Current Drug Targets · 2
Discovery of inhibitors of bacterial histidine kinases
2014 · N.R. Velikova · 1
PDF
Altered ivermectin pharmacology and defective visual system in Drosophila mutants for histamine receptor HCLB
2008 · Shazie Yusein, Nadya Velikova, et al. · Invertebrate Neuroscience · 1
PDF
Inhibidores de la histidina quinasa con actividad antibacteriana
2016 · Alberto Marina, Nadya Velikova, et al. · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Additional file 1: Figure S1. of Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis
2016 · Velikova, Nadya, Kavanagh, Kevin, et al. · Figshare
Nanodevices for delivery of therapeutics to cystic fibrosis patients
2015 · Lorena Polo Aguado Soledad Ordonez Alvarez, Nadya Velikova · Journal of Pharmaceutical Care & Health Systems
Interspecific variations in a histamine receptor gene, hclB, and primary characterization of the Drosophila melanogaster hclB mutants
2006 · Shazie Yusein-Myashkova, Nadya Velikova, et al. · Journal of Neurogenetics
Works count: 24
Citation count: 486
H-index: 9
I10-index: 9
Year
Topic
Type